Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

BACKGROUND: We aimed to determine the impact of tocilizumab use on severe COVID-19 (coronavirus disease 19) pneumonia mortality. METHODS: We performed a multicentre retrospective cohort study in 18 tertiary hospitals in Spain from March to April 2020. Consecutive patients admitted with severe COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Antorán, Belén, Sancho-López, Aránzazu, Torres, Ferrán, Moreno-Torres, Víctor, de Pablo-López, Itziar, García-López, Paulina, Abad-Santos, Francisco, Rosso-Fernández, Clara M., Aldea-Perona, Ana, Montané, Eva, Aparicio-Hernández, Ruth M., Llop-Rius, Roser, Pedrós, Consuelo, Gijón, Paloma, Hernández-Carballo, Carolina, Pedrosa-Martínez, María J., Rodríguez-Jiménez, Consuelo, Prada-Ramallal, Guillermo, Cabrera-García, Lourdes, Aguilar-García, Josefa A., Sanjuan-Jimenez, Rocío, Ortiz-Barraza, Evelyn I., Sánchez-Chica, Enrique, Fernández-Cruz, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719057/
https://www.ncbi.nlm.nih.gov/pubmed/33280066
http://dx.doi.org/10.1007/s40121-020-00373-8

Ejemplares similares

Ejemplares similares